Mexican Journal of Biomedical Engineering <center> <div class="page" title="Page 1"> <div class="layoutArea"> <div class="column"> <p>Call for Papers for Special Issue on “Biomedical Engineering Innovations for Coronavirus COVID-19”</p> </div> </div> </div> <p><a href="Call%20for Papers for Special Issue on “Biomedical Engineering Innovations for Coronavirus COVID-19”"><strong>DOWNLOAD FULL INFO HERE</strong></a></p> <p><strong>MISSION</strong></p> <p align="left"><em>La Revista Mexicana de Ingeniería Biomédica</em> (The Mexican Journal of Biomedical Engineering, RMIB, for its Spanish acronym) is a publication oriented to the dissemination of papers of the Mexican and international scientific community whose lines of research are aligned to the improvement of the quality of life through engineering techniques.</p> <p align="left">The papers that are considered for being published in the RMIB must be original, unpublished, and first rate, and they can cover the areas of Medical Instrumentation, Biomedical Signals, Medical Information Technology, Biomaterials, Clinical Engineering, Physiological Models, and Medical Imaging as well as lines of research related to various branches of engineering applied to the health sciences.</p> <p align="left">The RMIB is an electronic journal published quarterly ( January, May, September) by the Mexican Society of Biomedical Engineering,&nbsp; founded since 1980. It publishes articles in spanish and english and is aimed at academics, researchers and professionals interested in the subspecialties of Biomedical Engineering.</p> <p><strong>INDEXES</strong></p> <p><em>La revista Mexicana de Ingeniería Biomédica</em> is a quarterly publication, and it is found in the following indexes:</p> <p>&nbsp;<img src="/public/site/images/administrador/21.jpg" alt="" width="780" height="110"><img src="/public/site/images/administrador/1.jpg" alt="" width="780" height="110"><img src="/public/site/images/administrador/4.jpg" alt="" width="780" height="110"></p> <p><img src="/public/site/images/administrador/Unknown1.png" alt=""></p> </center> en-US <p>Upon acceptance of an article in the RMIB, corresponding authors will be asked to fulfill and sign the copyright and the journal publishing agreement, which will allow the RMIB authorization to publish this document in any media without limitations and without any cost. Authors may reuse parts of the paper in other documents and reproduce part or all of it for their personal use as long as a bibliographic reference is made to the RMIB and a copy of the reference is sent. However written permission of the Publisher is required for resale or distribution outside the corresponding author institution and for all other derivative works, including compilations and translations.</p> <p>&nbsp;</p> (Prof. Cesár Antonio González Díaz) (Carla Guerrero) Fri, 15 May 2020 00:00:00 +0000 OJS 60 Contenido Vol. 41 No. 2 (2020) <p>- Información general</p> <p>- Comité Editorial</p> <p>- Mesa Directiva</p> <p>- Índice</p> Copyright (c) Fri, 15 May 2020 00:00:00 +0000 Editor's Letter <p>La Revista Mexicana de Ingeniería Biomédica (The Mexican Journal of Biomedical Engineering), órgano oficial de divulgación de la Sociedad Mexicana de Ingeniería Biomédica, se ha consolidado como una de las mejores revistas científica de su campo en América Latina, tal logro es el resultado de 41 años de un esfuerzo continuo de muchas personas.</p> Copyright (c) Fri, 01 May 2020 00:00:00 +0000 Development and Simulation of an Automated Control Algorithm for Insulin Therapy of Hyperglycemic Emergencies in Diabetes <p>El presente trabajo describe el desarrollo y simulación de un algoritmo para el control automático de la infusión de insulina en del manejo glucémico de pacientes con cetoacidosis diabética (CAD) y estado hiperosmolar hiperglucémico (EHH). Se programó un software que calcula la insulina necesaria para un descenso glucémico de 50mg/dL/h hasta llegar a glucemias de 250mg/dL, para posteriormente mantenerlas en 220mg/dL hasta la remisión de la patología. La simulación del software se realizó haciendo uso de registros glucémicos de 10 pacientes con CAD manejados en el Hospital Juárez de México. Los resultados de la simulación mostraron una menor incidencia de hipoglucemias, así como un menor requerimiento de insulina dentro del tratamiento, sin diferencias entre los descensos medios de glucosa por hora de las mediciones reales y simuladas. Este software propone un uso innovador de los llamados páncreas artificiales al aplicarlos en urgencias hiperglucémicas, implementando además el uso de la sensibilidad a la insulina como variable para el funcionamiento de los mismos. Los resultados demuestran que el algoritmo podría ser capaz de lograr un manejo glucémico apegado a las guías de tratamiento, generando un menor gasto de insulina y evitando hipoglucemias durante la terapéutica, con una posible aplicación en dispositivos biomédicos autónomos.</p> Jared Becerril Rico Copyright (c) 2020 Jared Becerril Rico Fri, 15 May 2020 02:58:29 +0000